Dr. Karen Keough, MD
NPI: 1538147707
Total Payments
$395,521
2024 Payments
$113,376
Companies
52
Transactions
1,000
Payment Breakdown by Category
Other$302,146 (76.4%)
Travel$38,239 (9.7%)
Consulting$34,780 (8.8%)
Food & Beverage$19,889 (5.0%)
Education$466.82 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $212,004 | 111 | 53.6% |
| Honoraria | $73,111 | 25 | 18.5% |
| Travel and Lodging | $38,239 | 183 | 9.7% |
| Consulting Fee | $34,780 | 20 | 8.8% |
| Food and Beverage | $19,889 | 642 | 5.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,375 | 9 | 3.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,656 | 1 | 0.4% |
| Education | $466.82 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $108,079 | 130 | $0 (2024) |
| SK Life Science, Inc. | $82,968 | 121 | $0 (2024) |
| LivaNova USA, Inc. | $70,121 | 219 | $0 (2024) |
| Greenwich Biosciences, Inc. | $64,906 | 89 | $0 (2021) |
| UCB, Inc. | $35,055 | 112 | $0 (2024) |
| BIOCODEX, INC. | $9,691 | 11 | $0 (2024) |
| Zogenix Inc. | $7,326 | 9 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $3,880 | 7 | $0 (2024) |
| Cyberonics, Inc. | $2,884 | 12 | $0 (2017) |
| AQUESTIVE THERAPEUTICS, INC. | $2,521 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113,376 | 229 | SK Life Science, Inc. ($52,028) |
| 2023 | $91,323 | 180 | JAZZ PHARMACEUTICALS INC. ($40,525) |
| 2022 | $71,152 | 170 | JAZZ PHARMACEUTICALS INC. ($39,077) |
| 2021 | $29,669 | 77 | Greenwich Biosciences, Inc. ($14,174) |
| 2020 | $25,122 | 75 | Greenwich Biosciences, Inc. ($20,259) |
| 2019 | $41,869 | 116 | Greenwich Biosciences, Inc. ($30,473) |
| 2018 | $15,739 | 94 | LivaNova USA, Inc. ($14,733) |
| 2017 | $7,272 | 59 | LivaNova USA, Inc. ($3,684) |
All Payment Transactions
1,000 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neurology | ||||||
| 12/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Neurology | ||||||
| 12/17/2024 | AQUESTIVE THERAPEUTICS, INC. | LIBERVANT (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Central Nervous System | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.99 | General |
| 11/29/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/28/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,720.00 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $62.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | AQUESTIVE THERAPEUTICS, INC. | LIBERVANT (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Neurology | ||||||
| 11/21/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: Neurology | ||||||
| 11/17/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Neurology | ||||||
| 11/12/2024 | SK Life Science, Inc. | — | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| 11/12/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.19 | General |
| 11/07/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Neurology | ||||||
| 11/01/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Neurology | ||||||
| 10/31/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Neurology | ||||||
| 10/31/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Neurology | ||||||
| 10/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 10/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Neurology | ||||||
| 10/29/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: RETT SYNDROME | ||||||
| 10/24/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Neurology | ||||||
| 10/23/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $277.96 | General |
| Category: NEUROLOGY | ||||||
About Dr. Karen Keough, MD
Dr. Karen Keough, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538147707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Keough, MD has received a total of $395,521 in payments from pharmaceutical and medical device companies, with $113,376 received in 2024. These payments were reported across 1,000 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($212,004).
Ad
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Other Specialties Clinical Neurophysiology, Epilepsy
- Location Austin, TX
- Active Since 01/06/2006
- Last Updated 03/27/2025
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1538147707
Products in Payments
- EPIDIOLEX (Drug) $108,079
- XCOPRI (Drug) $78,461
- Epidiolex (Drug) $64,906
- Fintepla (Drug) $41,356
- VNS Therapy (Device) $39,658
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $17,369
- DIACOMIT (Drug) $9,691
- VNS Therapy SenTiva Model 1000 Generator (Device) $9,462
- VNS - Sentiva (Device) $6,516
- SYMPAZAN (Drug) $2,527
- APTIOM (Drug) $901.50
- RNS Neurostimulator Kit (Device) $534.91
- Cenobamate (Drug) $445.50
- Briviact (Drug) $427.54
- VIGADRONE (Drug) $333.16
- DAYBUE (Drug) $279.62
- Adzenys XR-ODT (Drug) $259.66
- TROKENDI XR (Drug) $255.05
- VYVANSE (Drug) $212.67
- Fycompa (Drug) $191.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Austin
Mr. Shelly Reardon, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $17,555
Neurology with Special Qualifications in Child Neurology $17,555
Dr. Samantha Irwin, Mb Bch Bao; Frcpc, MB BCH BAO; FRCPC
Neurology with Special Qualifications in Child Neurology — Payments: $7,394
Neurology with Special Qualifications in Child Neurology $7,394
Dr. Jinfon Ong, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $6,931
Neurology with Special Qualifications in Child Neurology $6,931
Dr. Dilip Karnik, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $3,179
Neurology with Special Qualifications in Child Neurology $3,179
Mrs. Toshia Mckeon, Rn, Cpnp, RN, CPNP
Neurology with Special Qualifications in Child Neurology — Payments: $3,083
Neurology with Special Qualifications in Child Neurology $3,083
Dr. Jeffrey Kerr, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $2,253
Neurology with Special Qualifications in Child Neurology $2,253